Overview

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This multiple ascending dose study is to determine the safety and bronchodilator activity of TRN-157 in 59 mild and moderate asthmatics.
Phase:
Phase 2
Details
Lead Sponsor:
Theron Pharmaceuticals, Inc.
Treatments:
Tiotropium Bromide